Full text loading...
Beta-amyloid (Aβ) likely plays a pivotal role in the etiology of Alzheimer's disease (AD). Consequently, Aβ-associated pathways are targets for the development of possible effective AD therapies. This review first updates strategies aimed at the inhibition of Aβ formation and then discusses the role of food-derived polyphenols as putative antiamyloid drugs.